- Companies
- i-SENS
i-SENS Valuation Multiples
i-SENS is valued at $339M as of September 2026, a 1.7x revenue multiple. In the last 12 months, i-SENS revenue was $241M and i-SENS EBITDA was $22M.
i-SENS Overview
About i-SENS
i-SENS Inc is a Korean company which is engaged in the manufacture and sale of biosensors. The product portfolio of the company includes blood glucose monitoring systems, including blood glucose monitors, blood glucose meters, glucose monitors, blood glucose meter kits and blood sugar meters under the brand names of CareSens, MedTrust, BGStar, Barozen and others.
Founded
2000
HQ
Employees
N/A
Website
Financials (LTM)
EV
$417M
Valuation Multiples
Start free triali-SENS Financials
i-SENS reported last 12-month revenue of $241M and EBITDA of $22M.
In the same LTM period, i-SENS generated $103M in gross profit, $22M in EBITDA, and $5M in net income.
Revenue (LTM)
i-SENS P&L
In the most recent fiscal year, i-SENS reported revenue of $231M and EBITDA of $8M.
i-SENS is unprofitable as of last fiscal year, with gross margin of 40%, EBITDA margin of 3%, and net margin of (2%).
Financial data powered by Morningstar, Inc.
i-SENS Stock Performance
i-SENS has current market cap of $339M, and enterprise value of $417M.
Market Cap Evolution
i-SENS's stock price is $11.77.
i-SENS share price decreased by 10.3% in the last 30 days, and by 15.2% in the last year.
i-SENS has an EPS (earnings per share) of $-0.13.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $417M | $339M | 1.9% | -10.3% | 12.8% | -15.2% | $-0.13 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free Triali-SENS Valuation Multiples
i-SENS trades at 1.7x EV/Revenue multiple, and 18.7x EV/EBITDA.
EV / Revenue (LTM)
i-SENS Financial Valuation Multiples
As of September 23, 2026, i-SENS has market cap of $339M and EV of $417M.
i-SENS has a P/E ratio of 67.4x.
Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified i-SENS Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.


i-SENS Margins & Growth Rates
i-SENS grew revenue by 9% and EBITDA by 203% in the last fiscal year.
In the most recent fiscal year, i-SENS reported gross margin of 40%, EBITDA margin of 3%, and net margin of (2%).
i-SENS Margins
i-SENS Growth Rates
Data powered by FactSet, Inc. and Morningstar, Inc.
i-SENS Operational KPIs
i-SENS's Rule of 40 is 19% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
i-SENS's Rule of X is 33% (created by Bessemer, Rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
Data powered by FactSet, Inc. and Morningstar, Inc.
i-SENS Competitors
i-SENS competitors include Beijing Piesat Informatio, Seeing Machines, General Oceans, Aeluma, SAIMO, Immersion, ECARX Group, Gooch & Housego, Sensortek and Stemmer Imaging.
Most i-SENS public comparables operate across Sensors & Monitoring and Industry 4.0.
| Last FY | EV/Revenue | EV/EBITDA | ||||||
|---|---|---|---|---|---|---|---|---|
| Revenue | EBITDA | Last FY | LTM | 2027E | Last FY | LTM | 2027E | |
| $67M | ($213M) | 9.0x | 6.6x | (2.8x) | - | |||
| $62M | ($6M) | 5.5x | 4.0x | (57.9x) | 51.6x | |||
| $136M | $27M | 2.6x | 2.4x | 13.2x | 11.1x | |||
| $4M | ($10M) | 47.9x | 50.5x | (22.0x) | (32.7x) | |||
| $39M | $21M | 5.6x | - | 10.7x | - | |||
| $1.7B | $69M | 0.3x | 0.3x | 8.3x | - | |||
| $848M | ($23M) | 1.1x | 1.0x | (41.5x) | 58.0x | |||
| $201M | $27M | 2.5x | 2.2x | 18.7x | 13.6x | |||
This data is available for Pro users. Sign up to see all i-SENS competitors and their valuation data. Start Free Trial | ||||||||
Acquisitions by i-SENS
i-SENS has acquired 2 companies to date.
Last acquisition by i-SENS was on May 17th 2023. i-SENS acquired AgaMatrix for $27M (EV/Revenue multiple available to Pro users).
Latest Acquisitions by i-SENS
| Description | AgaMatrix is a Salem, New Hampshire-headquartered developer of diabetes management devices. Its WaveSense technology powers blood glucose meters that correct for hematocrit, temperature, and strip variations, achieving high accuracy. The product line includes JAZZ and PRECIO meters, with Zero-Click data management software. Protected by over 160 patents, the FDA-cleared devices are distributed globally through partnerships with retailers and pharma companies. | CoaguSense is a manufacturer of point-of-care PT/INR monitoring systems for anticoagulation management. U.S.-based, its devices deliver lab-accurate results in seconds using fingerstick samples. Distributed to clinics and home users, the systems support warfarin therapy with data connectivity to EHRs. |
| HQ Country | ||
| HQ City | - | San Francisco, CA |
| Deal Date | 17 May 2023 | 1 Dec 2016 |
| Valuation | $27M | undisclosed |
| EV/Revenue | ||
| EV/EBITDA | ||
This data is available for Pro users. Sign up to see all i-SENS acquisitions and their M&A valuation multiples. Start Free Trial | ||
Investments by i-SENS
i-SENS has invested in 1 company to date.
Latest investment by i-SENS was on November 6th 2023. i-SENS invested in Caremedi in their $20M Series B round (EV/Revenue multiple available to Pro users).
Latest Investments by i-SENS
| Description | - |
| HQ Country | |
| HQ City | - |
| Deal Date | 6 Nov 2023 |
| Round | Series B |
| Raised | $20M |
| Investors | AJU IB Investment Co; i-SENS; Korea Investment Partners; Company K Partners; Atinum Investment |
| Valuation | undisclosed |
| EV/Revenue | |
| EV/EBITDA | |
This data is available for Pro users. Sign up to see all i-SENS investments and their VC round multiples. Start Free Trial | |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout i-SENS
| Who are competitors of i-SENS? | i-SENS main competitors include Beijing Piesat Informatio, Seeing Machines, General Oceans, Aeluma, SAIMO, Immersion, ECARX Group, Gooch & Housego, Sensortek, Stemmer Imaging. |
See public comps similar to i-SENS
Lists including i-SENS
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.




